Becker's Healthcare December 13, 2024
A new report from the Institute for Clinical and Economic Review showed that recent unsupported price hikes for top-selling drugs contributed to $815 million to U.S. medical spending in 2023.
Here are three things to know:
- The analysis, which assessed the top 10 drugs with the largest net price increases, found that five of these drugs raised prices without new clinical evidence to justify the increases.
- Among the...